ARTICLE | Distillery Therapeutics
Cancer
October 31, 2018 8:28 PM UTC
Cell culture studies identified an oligomer macrocycle-based inhibitor of the β-catenin-TCF4 interaction that could help treat prostate cancer. Chemical synthesis of oligomer macrocycles designed to i...